John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 564 shares at $17.06 ($10K) on 2023-10-20, disclosed to the SEC on 2023-10-25.
Open-market sale of $10k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2026-02-20 | $4K | — | Filing → |
| RCKT | SELL | 2026-02-18 | $12K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |